Summary & Overview
HCPCS G2155: Documentation of Contraindication to Tdap/Td Vaccination
HCPCS Level II code G2155 documents a patient history of major contraindications to tetanus-containing vaccines, including anaphylaxis to Tdap or Td or vaccination-associated encephalopathy. Nationally, a standardized code for documenting these contraindications supports accurate immunization records, patient safety, and appropriate exclusion from vaccine administration when clinically indicated. This coding can affect quality measurement, vaccination coverage reporting, and clinical workflow for providers assessing vaccine suitability.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare and Medicare. Readers will find a concise explanation of the code's clinical context, typical settings where it is used, and the implications for billing and documentation. The publication outlines benchmarks and reporting considerations, recent policy updates relevant to vaccine safety documentation, and operational factors for clinicians and billing staff managing immunization contraindications. Data not available in the input is explicitly noted where applicable, and the focus remains on national applicability rather than state-specific rules.
Billing Code Overview
HCPCS Level II code G2155 indicates that a patient has a documented history of at least one specified contraindication to tetanus-containing vaccination. The listed contraindications include anaphylaxis due to Tdap vaccine, anaphylaxis due to Td vaccine or its components, and encephalopathy associated with Tdap or Td vaccination (for example, post-tetanus, post-diphtheria, or post-pertussis vaccination encephalitis).
Service Type: Contraindication documentation / immunization exclusion note
Typical Site of Service: Outpatient clinical settings such as primary care offices, specialty clinics, and immunization clinics where vaccination history and contraindications are assessed and documented.
Clinical & Coding Specifications
Clinical Context
A patient with a documented history of a serious adverse reaction to tetanus-containing vaccines presents for routine preventive care or wound management. During intake, the clinician reviews immunization history and finds prior anaphylaxis to Tdap or Td or a history of post-vaccination encephalopathy attributed to tetanus/diphtheria/pertussis components. The clinical workflow includes verification of the contraindication in the medical record, counseling the patient that tetanus-containing vaccines are contraindicated, documenting the specific reaction and source of information (patient report, historical medical record, or allergy/immunization registry), and recording the contraindication using billing code G2155 for quality measures and reporting. Typical sites of service include primary care clinics, urgent care centers, emergency departments when presenting with wounds, and public health clinics where immunizations are otherwise administered. The typical patient scenario: an adult with a laceration from a farm injury who reports prior anaphylaxis to Tdap as a teenager; the clinician evaluates wound risk, documents the contraindication G2155, considers alternative management strategies (e.g., tetanus immunoglobulin if indicated), and records the encounter in the allergy list and immunization registry.
Coding Specifications
| Modifier | Description | When to Use |
|---|